Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms
- 1 January 2015
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (1) , 1-16
Abstract
No abstract availableKeywords
This publication has 217 references indexed in Scilit:
- Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in ratPsychopharmacology, 2011
- Antipsychotic drugs and obesityTrends in Molecular Medicine, 2011
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)European Psychiatry, 2009
- CXC Ligand 5 Is an Adipose-Tissue Derived Factor that Links Obesity to Insulin ResistanceCell Metabolism, 2009
- Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectinSchizophrenia Research, 2008
- Ins (endocytosis) and outs (exocytosis) of GLUT4 traffickingCurrent Opinion in Cell Biology, 2007
- Inflammation and metabolic disordersNature, 2006
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001